Latest CDC data shows measles cases in Missouri for 2025 are now estimated within the range of 1-9, marking no change compared to the previous figures updated as of week ending Aug. 9.
Missouri businesses are preparing for changes to paid sick leave requirements following the passage of House Bill 567 (HB 567), which repeals the Earned Paid Sick Time (EPST) provisions established by Proposition A (Prop A).
Alexei Demchenko, Ph.D., chair of the chemistry department at Saint Louis University (SLU), has been named a Fellow of the American Chemical Society (ACS) for 2025.
A Cole County judge has denied a request for a temporary restraining order that would have halted the implementation of House Bill 12, Missouri’s recent investment in school choice.
The National Federation of Independent Business (NFIB) has launched a new advertising campaign in Missouri’s 8th District to thank Representative Jason Smith for his role in making the 20% Small Business Tax Deduction permanent.
Federal authorities have unsealed an indictment charging Kurbin Menaugh, 36, and Robert Terry, 44, with conspiracy to possess and distribute methamphetamine.
The Missouri Agricultural and Small Business Development Authority (MASBDA) has opened applications for the Show-Me Entrepreneurial Grants for Agriculture (SEGA) Innovation Grant Program.
Scale AI has announced plans to open a new artificial intelligence center in St. Louis’ historic Post Building, marking an expansion of its operations within the city’s growing geospatial and defense technology sector.
Greater St. Louis, Inc. Interim CEO Dustin Allison responded to Missouri Governor Mike Kehoe's decision to appoint Catherine Hanaway as the state's new Attorney General.
Fr. Thomas Sserwadda, a doctoral student at Saint Louis University (SLU), has helped connect students in Uganda with musical instruments through a recent donation project.
Nearly forty businesses from the St. Louis area have been recognized on the 2025 Inc. 5000 list, which highlights the fastest-growing private companies in the United States.
Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, has highlighted concerns regarding the structure of the 340B Drug Pricing Program.